Alpha Omega Wealth Management LLC Cellectis S.A. Transaction History

Alpha Omega Wealth Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$10.15 - $16.89 $913 - $1,520	-90 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$14.6 - $20.6 $584 - $824	-40 Reduced 30.77%	90 $1,000
Q1 2019 May 02, 2019	BUY	$15.53 - $19.75 $776 - $987	50 Added 62.5%	130 $2,000
Q3 2017 Nov 03, 2017	BUY	$21.65 - $32.18 $1,732 - $2,574	80	80 $2,000

11.2M

5.9K

1.4K

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $88.3M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

Get notified when there are updates to the investment portfolio of Alpha Omega Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Omega Wealth Management LLC with notifications on news.